Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced Myopathies.

Jürgen Steinmeyer1, Johannes Flechtenmacher2,3

  • 1Laboratory for Experimental Orthopaedics, Dept. of Orthopaedics, Justus Liebig University Giessen, Giessen, Germany.

Zeitschrift Fur Orthopadie Und Unfallchirurgie
|July 28, 2021
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Identification of joint-specific risk factors for risk adjustment in total knee arthroplasty-A modified Delphi process].

Orthopadie (Heidelberg, Germany)·2026
Same author

Low dose NSAIDs and sysadoas in the management of knee osteoarthritis.

Aging clinical and experimental research·2025
Same author

Phospholipids and Sphingolipids in Osteoarthritis.

Biomolecules·2025
Same author

Degenerative Shoulder Diseases: Shoulder Injuries, Epidemiology, ICD10, Coding.

Zeitschrift fur Orthopadie und Unfallchirurgie·2024
Same author

Functional Insights into the Sphingolipids C1P, S1P, and SPC in Human Fibroblast-like Synoviocytes by Proteomic Analysis.

International journal of molecular sciences·2024
Same author

Socioeconomic differences in the utilization of diagnostic imaging and non-pharmaceutical conservative therapies for spinal diseases.

BMC musculoskeletal disorders·2023

Drug-induced toxic myopathy is a significant cause of muscle pain and weakness. Early identification of medication or alcohol use is crucial for diagnosis and reversible treatment.

Area of Science:

  • Neurology
  • Toxicology
  • Pharmacology

Background:

  • Muscle pain and weakness have diverse causes, including neurological, genetic, and toxic factors.
  • Medications and toxins are common culprits in muscle disorders, with alcohol misuse, lipid-lowering drugs, and corticosteroids being frequent causes of toxic myopathy.
  • Drug interactions, particularly those involving CYP3A4 metabolism, can elevate drug levels and exacerbate toxicity.

Purpose of the Study:

  • To highlight the differential diagnosis of muscle pain and weakness.
  • To emphasize the role of medications and toxins in causing myopathy.
  • To underscore the importance of patient history in identifying drug-induced causes.

Main Methods:

  • Review of potential aetiologies for muscle pain and weakness.

Related Experiment Videos

  • Analysis of drug classes and substances implicated in toxic myopathy.
  • Discussion of clinical presentation, pathogenesis, and management strategies.

    • Main Results:

    • Muscle sensitivity to drugs is dose-dependent, with varied clinical presentations from asymptomatic creatine kinase elevation to severe rhabdomyolysis and kidney failure.
    • Alcohol misuse, lipid-lowering drugs, and corticosteroids are frequently associated with toxic myopathy.
    • Drug interactions can potentiate toxicity by increasing serum drug levels.

    Conclusions:

    • A thorough patient history of drug and alcohol consumption is vital for diagnosing toxic myopathy.
    • Toxic myopathy is often reversible upon drug discontinuation or dose adjustment.
    • Preventing complications like acute kidney failure and providing symptomatic relief are key management goals.